Nonanticoagulant heparin inhibits NF-kappaB activation and attenuates myocardial reperfusion injury.
about
Regulation of IkappaBalpha function and NF-kappaB signaling: AEBP1 is a novel proinflammatory mediator in macrophagesHeparin: Past, Present, and FutureTransmembrane Protein 184A Is a Receptor Required for Vascular Smooth Muscle Cell Responses to HeparinLow anticoagulant heparin targets multiple sites of inflammation, suppresses heparin-induced thrombocytopenia, and inhibits interaction of RAGE with its ligands.Stepwise inhibition of T cell recruitment at post-capillary venules by orally active desulfated heparins in inflammatory arthritisNonanticoagulant heparin reduces myocyte Na+ and Ca2+ loading during simulated ischemia and decreases reperfusion injury.Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling.Clinical review: anticoagulation for continuous renal replacement therapy--heparin or citrate?Polyphosphate elicits pro-inflammatory responses that are counteracted by activated protein C in both cellular and animal models.Heparin reduces neuroinflammation and transsynaptic neuronal apoptosis in a model of subarachnoid hemorrhage.Effect of N-desulfated heparin on hepatic/renal ischemia reperfusion injury in ratsHeparin Decreases in Tumor Necrosis Factor α (TNFα)-induced Endothelial Stress Responses Require Transmembrane Protein 184A and Induction of Dual Specificity Phosphatase 1.Heparin and LPS-induced COX-2 expression in airway cells: a link between its anti-inflammatory effects and GAG sulfation.The non-anticoagulant heparin-like K5 polysaccharide derivative K5-N,OSepi attenuates myocardial ischaemia/reperfusion injuryRole of tumour necrosis factor-alpha and other cytokines in ischemia-reperfusion-induced injury in the heart.Effects of heparin and related molecules upon neutrophil aggregation and elastase release in vitro.Systemic administration of heparin ameliorates radiation-induced oral mucositis-preclinical studies in mice.
P2860
Q21296830-43AA65B5-C63C-47DB-9411-B5C25369BD2DQ26744227-20AA9F4E-23F0-4F51-B9D4-E00CCA03ABA0Q28567433-7609DD9B-8C0A-4387-A3BE-2EB948283C68Q33389069-76EDE45A-922B-41B1-BEAC-6103FF83050AQ33574588-4414DAD6-8C26-4ADA-B6E2-97892F0872CFQ33589221-F7FD973E-1539-42B1-B648-CEAF1300E486Q34960679-CAEB7106-9CB4-4E4C-B58E-10A2A02640C4Q35567100-8B3995D2-42A2-4CEF-8903-F2A7635C4875Q36003987-3DF73483-0CB8-4358-BE47-AFB57852E595Q36025124-6AB6FD45-98CF-4A0E-80FF-BC32A19754A2Q36309004-3B4A708A-F941-482D-BE3D-0DA1E31B984CQ36650401-C3EEA786-76C4-4D31-87B7-ED07543F6671Q37129696-65703DB9-0790-4717-AE57-7523CD99EAE1Q37294940-3244ACDC-63E5-487F-82B6-2D14AD4A8A21Q41824383-15E56178-B257-4274-9032-8FC2EBA2C8EEQ41935530-5F0BFF93-ED07-43F0-84BC-CB3163FEEADEQ52584133-1DA43735-2D71-425F-8A49-368F2A0352E9
P2860
Nonanticoagulant heparin inhibits NF-kappaB activation and attenuates myocardial reperfusion injury.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Nonanticoagulant heparin inhib ...... myocardial reperfusion injury.
@ast
Nonanticoagulant heparin inhib ...... myocardial reperfusion injury.
@en
type
label
Nonanticoagulant heparin inhib ...... myocardial reperfusion injury.
@ast
Nonanticoagulant heparin inhib ...... myocardial reperfusion injury.
@en
prefLabel
Nonanticoagulant heparin inhib ...... myocardial reperfusion injury.
@ast
Nonanticoagulant heparin inhib ...... myocardial reperfusion injury.
@en
P2093
P2860
P1476
Nonanticoagulant heparin inhib ...... myocardial reperfusion injury.
@en
P2093
Kennedy TP
Sturrock AL
Thornton LR
Thourani VH
Vinten-Johansen J
P2860
P304
P356
10.1152/AJPHEART.2000.278.6.H2084
P577
2000-06-01T00:00:00Z